Targeting LIMK1 with luteolin inhibits the growth of lung cancer in vitro and in vivo

Journal of Cellular and Molecular Medicine

Feng Zhu¹  Rui Wang²  Jie Tian²  Man Zhang²  Ran Zhao³  Zigang Dong³  Mengqiu Song³  Kangdong Liu³  Mee‐Hyun Lee⁴  Jung‐Hyun Shim⁵ 

[1] Cancer Research Institute, The Affiliated Hospital of Guilin Medical University, Guilin, China;China‐US (Henan) Hormel Cancer Institute, Zhengzhou, China;China‐US (Henan) Hormel Cancer Institute, Zhengzhou, China;Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China;China‐US (Henan) Hormel Cancer Institute, Zhengzhou, China;Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China;College of Korean Medicine, Dongshin University, Naju, Republic of Korea;Department of Pharmacy, College of Pharmacy, Mokpo National University, Muan, Republic of Korea;

关键词: LIMK1;    luteolin;    non‐small cell lung cancer;   

DOI  :  10.1111/jcmm.16568

来源: Wiley

【 授权许可】

CC BY